This text is a result of machine translation.
Aimeike signs distribution cooperation framework agreement with South Korea huons BP
The steel sector strengthened significantly
Baijiu plate strength, mouth cellar line exceeds 10%
AMEC: the capital increase and acquisition of part of the equity of hoons biopharma in South Korea have been completed
The investment banking business was strictly supervised, and seven securities companies received fines
Insilico Medicine (英矽智能) Signs Strategic Drug Discovery Partnership with Takeda (武田制药), Deal Worth Up to US$600 Million
Chinese AI drug discovery company Insilico Medicine (英矽智能) has signed a global strategic collaboration with Japanese pharmaceutical company Takeda (武田制药), with the total potential deal value reaching up to US$600 million. Announced in early July, the agreement marks another milestone in the international commercialization of China's AI-powered drug discovery technologies through collaboration with a leading multinational pharmaceutical company.
Jul 16, 2026 02:33 PM
The first batch of "Mao" concept achievements were released, with a year-on-year growth of more than 50%
The medical and American plate rose sharply
AMEC: the net profit in the first half of the year was 425 million yuan, a year-on-year increase of 188.86%
Aimike's reply to the letter of concern: after obtaining the equity of huons bio, it will not have a significant adverse impact on the company's production and operation
A Small Aircraft, a Bigger Bet: How China's Worthy Aero Plans to Scale Up
Jul 28, 2026 03:24 PM
EqualOcean Releases 2026 Chinese GoGlobal Physical Retail Brands Top 10 at GGF2026
Jun 17, 2026 02:50 PM